Cliff Asness's ABEO Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 114,520 shares of Abeona Therapeutics Inc. (ABEO) worth $603,520, representing 0.00% of the portfolio. First purchased in 2017-Q3, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ABEO, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 80,908 shares. Largest reduction occurred in Q1 2021, reducing 7,082 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Abeona Therapeutics (ABEO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Abeona Therapeutics (ABEO) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +80,908 | Add 240.71% | 114,520 | $5.27 |
| Q3 2025 | +33,612 | New Buy | 33,612 | $5.28 |
| Q1 2021 | -7,082 | Sold Out | 0 | $0.00 |
| Q4 2020 | +2,580 | Add 57.31% | 7,082 | $39.25 |
| Q3 2020 | -264 | Reduce 5.54% | 4,502 | $25.54 |
| Q2 2020 | +1,136 | Add 31.29% | 4,766 | $72.81 |
| Q1 2020 | +3,630 | New Buy | 3,630 | $52.62 |
| Q4 2019 | -1,479 | Sold Out | 0 | $0.00 |
| Q3 2019 | +1,479 | New Buy | 1,479 | $56.80 |
| Q4 2018 | -1,197 | Sold Out | 0 | $0.00 |
| Q3 2018 | -273 | Reduce 18.57% | 1,197 | $319.97 |
| Q2 2018 | -184 | Reduce 11.12% | 1,470 | $400.00 |
| Q1 2018 | -165 | Reduce 9.07% | 1,654 | $359.13 |
| Q4 2017 | +59 | Add 3.35% | 1,819 | $396.37 |
| Q3 2017 | +1,760 | New Buy | 1,760 | $426.14 |
Cliff Asness's Abeona Therapeutics Investment FAQs
Cliff Asness first purchased Abeona Therapeutics Inc. (ABEO) in Q3 2017, acquiring 1,760 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Abeona Therapeutics Inc. (ABEO) for 15 quarters since Q3 2017.
Cliff Asness's largest addition to Abeona Therapeutics Inc. (ABEO) was in Q4 2025, adding 114,520 shares worth $603,520.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 114,520 shares of Abeona Therapeutics Inc. (ABEO), valued at approximately $603,520.
As of the Q4 2025 filing, Abeona Therapeutics Inc. (ABEO) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Abeona Therapeutics Inc. (ABEO) was 114,520 shares, as reported at the end of Q4 2025.